Tumor-associated CTLA-4 has been shown to inhibit anti-tumor T cell immunity by interacting with CD28 expressed on T cells to induce tumor-specific T cell apoptosis or by impairing cytokine production and T cell-mediated cytotoxicity [43]. Here, CD28 is linked to neoplasm.